Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hayes

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Frontline Gastroenterology|August 15, 2023
Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgeryNadir Abbas, Jonathan Fallowfield, David Patch, et al.
BMC Medical Education|June 5, 2020
A feasibility study of an exercise intervention to educate and promote health and well-being among medical students: the 'MED-WELL' programmeAubree Worobetz, Petrus J Retief, Sinead Loughran, et al.
Plos One|October 25, 2011
Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trialsLycias Zembe, Wendy A Burgers, Heather B Jaspan, et al.
Plos One|July 2, 2026
Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoproteinHeejin Yun, Faith Sigei, Nana Yaa Asiedua Appiah, et al.
Journal of Virology|October 9, 2023
Mosaic HIV-1 vaccination induces anti-viral CD8<sup>+</sup> T cell functionality in the phase 1/2a clinical trial APPROACHJanine van Duijn, Daniel Stieh, Natalia Fernandez, et al.
Addiction (Abingdon, England)|March 2, 2021
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world dataNorah E Palmateer, Andrew McAuley, John F Dillon, et al.
Rural and Remote Health|April 27, 2026
Pae Ora - Healthy Futures: lessons learned from the first New Zealand Rural Health StrategyLiam Glynn, Sarah Clarke, Helen MacGregor, et al.
HRB Open Research|May 23, 2024
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: Protocol for a pilot cluster RCT of the MIAMI interventionEimear Morrissey, Andrew Murphy, Patrick Murphy, et al.
Clinical and Molecular Hepatology|May 12, 2026
Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohortJasmohan S Bajaj, Patrick S Kamath, Florence Wong, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-BissauKristoffer Jarlov Jensen, Victor Raúl Gómez Román, Sanne Skov Jensen, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Frontline Gastroenterology|August 15, 2023
Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgeryNadir Abbas, Jonathan Fallowfield, David Patch, et al.
BMC Medical Education|June 5, 2020
A feasibility study of an exercise intervention to educate and promote health and well-being among medical students: the 'MED-WELL' programmeAubree Worobetz, Petrus J Retief, Sinead Loughran, et al.
Plos One|October 25, 2011
Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trialsLycias Zembe, Wendy A Burgers, Heather B Jaspan, et al.
Plos One|July 2, 2026
Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoproteinHeejin Yun, Faith Sigei, Nana Yaa Asiedua Appiah, et al.
Journal of Virology|October 9, 2023
Mosaic HIV-1 vaccination induces anti-viral CD8<sup>+</sup> T cell functionality in the phase 1/2a clinical trial APPROACHJanine van Duijn, Daniel Stieh, Natalia Fernandez, et al.
Addiction (Abingdon, England)|March 2, 2021
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world dataNorah E Palmateer, Andrew McAuley, John F Dillon, et al.
Rural and Remote Health|April 27, 2026
Pae Ora - Healthy Futures: lessons learned from the first New Zealand Rural Health StrategyLiam Glynn, Sarah Clarke, Helen MacGregor, et al.
HRB Open Research|May 23, 2024
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: Protocol for a pilot cluster RCT of the MIAMI interventionEimear Morrissey, Andrew Murphy, Patrick Murphy, et al.
Clinical and Molecular Hepatology|May 12, 2026
Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohortJasmohan S Bajaj, Patrick S Kamath, Florence Wong, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-BissauKristoffer Jarlov Jensen, Victor Raúl Gómez Román, Sanne Skov Jensen, et al.
Pageof 13